PHILADELPHIA, June 26, 2023 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq:CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will join the Russell 2000®, Russell 3000® and Russell Microcap® Indexes following the conclusion of the 2023 Russell indexes annual reconstitution, effective upon the U.S. markets open today, June 26, 2023.
Read more at prnewswire.comCarisma Therapeutics to be Added to Russell 2000®, Russell 3000® and Russell Microcap® Indexes
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here